- Reminder - Changes to the Data Required on the Federal Drug Testing Custody and Control Form and the Alcohol Testing Form Required by the Federal Motor Carrier Safety Administration Beginning January 6, 2020 To ensure you are prepared on January 6, 2020, when the Federal Motor Carrier Safety Administration (FMCSA) Drug and Alcohol Clearinghouse (Clearinghouse) becomes operational, we want to remind you about an upcoming change related to recording information on the Federal Drug Testing Custody and Control Form (CCF) and Alcohol Testing Form (ATF). What Changed? The current versions of the CCF and ATF specifically permit the use of either the driver's social security number (SSN) or employee identification number (EIN) when completing the CCF or ATF. However, effective January 6, 2020, FMCSA is requiring that the commercial driver's license number (CDL) must be used instead of the SSN or EIN when FMCSA-covered drivers' positive drug or alcohol test results are reported to the Clearinghouse. Therefore, Employers, Consortia/Third Party Administrators (C/TPAs), Collection Sites, Laboratories, and Medical Review Officers (MROs) may want to ensure that their respective data systems can accommodate a donor identification number of up to 25 alphanumeric characters. What does this mean for Employers, C/TPAs, Collectors and Alcohol Technicians?
What does this mean for Laboratories? Laboratories who receive a CCF that indicates this is a FMCSA-regulated urine specimen but does not have the driver's CDL number listed in Step 1 C should process the urine specimen without delay, and send the results to the MRO. What does this mean for the MRO? When the MRO receives a laboratory-confirmed positive drug test result for a FMCSA-regulated employee, and the CCF is without the driver's CDL number and State of Issuance listed, the MRO should contact the driver, driver's employer or designated employer representative to obtain it. The MRO will report the verified positive test result in the Clearinghouse. For additional information, please visit https://clearinghouse.fmcsa.dot.gov or send an email to clearinghouse@dot.gov.
This guidance is not legally binding in its own right and will not be relied upon by the Department as a separate basis for affirmative enforcement action or other administrative penalty. Conformity with this guidance (as distinct from existing statute and regulations, including 49 CFR Parts 40 and 382) is voluntary only. Nonconformity with this guidance will not affect rights and obligations under existing statutes and regulation.
| ||||||||||||||||||
Reminder - Preparing for the Federal Motor Carrier Safety Administration Drug and Alcohol Clearinghouse
DEA’s National Prescription Drug Take Back Day: October 26, 2019
DEA's National Prescription Drug Take Back Day
The Drug Enforcement Administration (DEA) has scheduled another National Prescription Drug Take Back Day, to be held on Saturday October 26, 2019 from 10 a.m. to 2 p.m.
The Take Back Day aims to provide a safe, convenient, and responsible means of disposal, while also educating the general public about the potential for abuse of medications. The Take Back Day provides an opportunity for Americans to prevent drug addiction and overdose deaths.
This is a great opportunity for those who missed previous events, or who have subsequently accumulated unwanted, unused prescription drugs, to dispose of those medications easily and safely.
For more information, including a Collection Site Locator, public service announcements, resources and treatment information, please visit DEA's website https://takebackday.dea.gov/.
| ||||||||||||||||||
Preparing for the Federal Motor Carrier Safety Administration Drug and Alcohol Clearinghouse
Changes to the Data Required on the Federal Drug Testing Custody and Control Form and the Alcohol Testing Form Required by the Federal Motor Carrier Safety Administration Beginning January 6, 2020 To ensure you are prepared on January 6, 2020, when the Federal Motor Carrier Safety Administration (FMCSA) Drug and Alcohol Clearinghouse (Clearinghouse) becomes operational, we want to remind you about an upcoming change related to recording information on the Federal Drug Testing Custody and Control Form (CCF) and Alcohol Testing Form (ATF). What Changed? The current versions of the CCF and ATF specifically permit the use of either the driver's social security number (SSN) or employee identification number (EIN) when completing the CCF or ATF. However, effective January 6, 2020, FMCSA is requiring that the commercial driver's license number (CDL) must be used instead of the SSN or EIN when FMCSA-covered drivers' positive drug or alcohol test results are reported to the Clearinghouse. Therefore, Employers, Consortia/Third Party Administrators (C/TPAs), Collection Sites, Laboratories, and Medical Review Officers (MROs) may want to ensure that their respective data systems can accommodate a donor identification number of up to 25 alphanumeric characters. What does this mean for Employers, C/TPAs, Collectors and Alcohol Technicians?
What does this mean for Laboratories? Laboratories who receive a CCF that indicates this is a FMCSA-regulated urine specimen but does not have the driver's CDL number listed in Step 1 C should process the urine specimen without delay, and send the results to the MRO. What does this mean for the MRO? When the MRO receives a laboratory-confirmed positive drug test result for a FMCSA-regulated employee, and the CCF is without the driver's CDL number and State of Issuance listed, the MRO should contact the driver, driver's employer or designated employer representative to obtain it. The MRO will report the verified positive test result in the Clearinghouse. For additional information, please visit https://clearinghouse.fmcsa.dot.gov or send an email to clearinghouse@dot.gov.
This guidance is not legally binding in its own right and will not be relied upon by the Department as a separate basis for affirmative enforcement action or other administrative penalty. Conformity with this guidance (as distinct from existing statute and regulations, including 49 CFR Parts 40 and 382) is voluntary only. Nonconformity with this guidance will not affect rights and obligations under existing statutes and regulation.
| ||||||||||||||||||
Coming Soon: FMCSA CDL Drug and Alcohol Clearinghouse
Coming Soon: FMCSA CDL Drug and Alcohol Clearinghouse FMCSA has released new resources to help CDL drivers, their employers, C/TPAs, MROs, and SAPs prepare for their roles in the forthcoming Commercial Driver's License Drug and Alcohol Clearinghouse. Mandated by MAP-21, this online database will contain information on drug and alcohol program violations committed by drivers subject to 49 CFR Part 382. This will ensure that FMCSA enforcement staff, State Driver Licensing Agencies, and State law enforcement personnel, as well as motor carriers and other employers of CDL drivers, have real-time information about these drug and alcohol program violations. The Clearinghouse will be operational beginning January 6, 2020, with registration opening in fall 2019. Visit https://clearinghouse.fmcsa.dot.gov to learn more and to subscribe to receive email updates about the Clearinghouse from FMCSA, including when registration opens later this year. Please send any questions to clearinghouse@dot.gov.
| ||||||||||||||||||
DEA’s National Prescription Drug Take Back Day: April 27, 2019
DEA's National Prescription Drug Take Back Day The Drug Enforcement Administration (DEA) has scheduled another National Prescription Drug Take Back Day, to be held on Saturday April 27, 2019 from 10 a.m. to 2 p.m. The Take Back Day aims to provide a safe, convenient, and responsible means of disposal, while also educating the general public about the potential for abuse of medications. The Take Back Day provides an opportunity for Americans to prevent drug addiction and overdose deaths. This is a great opportunity for those who missed previous events, or who have subsequently accumulated unwanted, unused prescription drugs, to dispose of those medications easily and safely. For more information, including a Collection Site Locator, public service announcements, resources and treatment information, please visit DEA's website https://takebackday.dea.gov/.
| ||||||||||||||||||
